Daniel Tarsy, M.D.

Concepts (440)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Deep Brain Stimulation	14	2014	849	1.850	Why?
Parkinson Disease	34	2016	2885	1.780	Why?
Dyskinesia, Drug-Induced	20	2012	165	1.700	Why?
Botulinum Toxins	13	2016	191	1.390	Why?
Dystonia	12	2012	378	1.300	Why?
Subthalamic Nucleus	8	2014	203	1.060	Why?
Botulinum Toxins, Type A	6	2013	239	0.860	Why?
Essential Tremor	5	2013	160	0.820	Why?
Tremor	7	2013	197	0.810	Why?
Torticollis	7	2010	69	0.770	Why?
Parkinsonian Disorders	4	2016	285	0.700	Why?
Dyskinesias	3	2011	79	0.690	Why?
Antipsychotic Agents	15	2011	3075	0.650	Why?
Movement Disorders	10	2016	460	0.590	Why?
Dystonic Disorders	8	2011	354	0.590	Why?
Metoclopramide	6	2007	51	0.580	Why?
Levodopa	16	2012	221	0.550	Why?
Anti-Dyskinesia Agents	4	2001	24	0.540	Why?
Ventral Thalamic Nuclei	2	2013	43	0.490	Why?
Dopamine Antagonists	4	2007	278	0.460	Why?
Voice Disorders	2	2012	286	0.450	Why?
Sneezing	1	2013	16	0.430	Why?
Gait Disorders, Neurologic	3	2012	245	0.430	Why?
Injections, Intraocular	1	2013	36	0.430	Why?
Blepharospasm	1	2013	34	0.420	Why?
Apoptosis Regulatory Proteins	7	2011	1150	0.410	Why?
Antiparkinson Agents	7	2011	184	0.400	Why?
Antiparasitic Agents	1	2012	41	0.400	Why?
Voice Training	1	2012	44	0.380	Why?
Reflex	1	2013	376	0.370	Why?
Meige Syndrome	2	2001	12	0.370	Why?
Anticonvulsants	3	2008	1919	0.360	Why?
Speech Disorders	1	2012	178	0.360	Why?
Needles	1	2013	460	0.340	Why?
Neuromuscular Agents	3	2006	149	0.330	Why?
Dopamine	15	2009	1582	0.320	Why?
Psychotherapy, Group	1	2012	417	0.300	Why?
Basal Ganglia Diseases	4	2002	145	0.290	Why?
Dopamine Agents	1	2008	186	0.290	Why?
Akathisia, Drug-Induced	2	2006	66	0.270	Why?
Masticatory Muscles	1	2006	31	0.260	Why?
Fructose	1	2008	285	0.260	Why?
Piracetam	1	2006	88	0.250	Why?
Thalamus	3	2013	1048	0.250	Why?
Quinolones	1	2009	387	0.250	Why?
Jaw Diseases	1	2006	91	0.240	Why?
Gastroparesis	1	2007	143	0.240	Why?
Ulnar Neuropathies	1	2004	32	0.220	Why?
Globus Pallidus	4	2012	247	0.220	Why?
Stiff-Person Syndrome	2	2013	32	0.220	Why?
Spasm	1	2004	131	0.220	Why?
Nuclear Proteins	7	2011	5782	0.220	Why?
Dysarthria	1	2003	57	0.210	Why?
Neurology	1	2011	784	0.210	Why?
Extrapyramidal Tracts	1	2002	17	0.200	Why?
Multiple System Atrophy	1	2003	132	0.190	Why?
Acetamides	2	2001	260	0.190	Why?
Gait	3	2016	819	0.190	Why?
Carbidopa	4	2012	30	0.180	Why?
Polyradiculoneuropathy	1	2001	65	0.180	Why?
DNA-Binding Proteins	7	2011	9600	0.180	Why?
Diabetes Complications	1	2007	1318	0.170	Why?
Humans	115	2016	765926	0.170	Why?
Middle Aged	54	2016	223016	0.160	Why?
Injections, Intramuscular	4	2006	551	0.160	Why?
Verbal Behavior	2	2014	328	0.160	Why?
Severity of Illness Index	11	2016	15878	0.160	Why?
Whiplash Injuries	1	1998	15	0.150	Why?
Piperazines	1	2009	2546	0.150	Why?
Neurosurgical Procedures	1	2009	2077	0.150	Why?
Neurologic Examination	3	2006	913	0.150	Why?
Neck Pain	1	1999	190	0.150	Why?
Myasthenia Gravis	1	2000	214	0.140	Why?
Aged	37	2016	171163	0.140	Why?
Deglutition Disorders	1	2003	640	0.140	Why?
Electric Stimulation Therapy	1	2003	634	0.140	Why?
Gastrointestinal Agents	1	2002	511	0.140	Why?
Haloperidol	5	1996	394	0.140	Why?
Neuroleptic Malignant Syndrome	2	1996	74	0.140	Why?
Attitude of Health Personnel	1	2011	3928	0.140	Why?
Nortropanes	1	2016	13	0.140	Why?
Monitoring, Ambulatory	2	2010	357	0.140	Why?
Sialorrhea	1	2016	25	0.130	Why?
Occupational Diseases	1	2004	1456	0.130	Why?
Brachial Plexus	1	1997	171	0.130	Why?
Cervical Vertebrae	2	2001	978	0.120	Why?
Serotonin Antagonists	1	1996	146	0.120	Why?
Muscle Spasticity	1	1996	159	0.120	Why?
Male	62	2016	363815	0.120	Why?
Bartonella henselae	1	1995	15	0.120	Why?
Cat-Scratch Disease	1	1995	23	0.120	Why?
Motor Activity	8	2014	2705	0.120	Why?
Spinal Injuries	1	1998	300	0.120	Why?
Tourette Syndrome	2	1996	400	0.120	Why?
Female	49	2016	396141	0.120	Why?
Epilepsies, Myoclonic	1	1995	83	0.120	Why?
Treatment Outcome	16	2016	65194	0.110	Why?
Electric Injuries	1	1994	24	0.110	Why?
Intracranial Embolism and Thrombosis	1	1993	143	0.110	Why?
Risperidone	1	1996	383	0.110	Why?
Receptors, Dopamine	5	1984	291	0.110	Why?
Functional Laterality	6	2012	2243	0.110	Why?
Adult	40	2016	223088	0.110	Why?
Neuroprotective Agents	1	2000	959	0.110	Why?
Risk	5	2009	9599	0.100	Why?
Physicians	1	2011	4591	0.100	Why?
Dystonia Musculorum Deformans	5	2010	158	0.100	Why?
Amantadine	3	2012	58	0.100	Why?
Subthalamus	1	2012	4	0.100	Why?
Physical Therapy Modalities	2	2006	532	0.100	Why?
Quality of Life	4	2013	13463	0.100	Why?
Catechols	1	2012	63	0.100	Why?
Leg Injuries	1	1994	180	0.100	Why?
Drug Resistance	2	2009	1588	0.100	Why?
Speech Therapy	1	2012	58	0.100	Why?
Coma	2	1995	485	0.100	Why?
Mutation, Missense	7	2010	2589	0.090	Why?
Codon	5	2010	599	0.090	Why?
Outpatient Clinics, Hospital	1	2013	391	0.090	Why?
Tomography, Emission-Computed, Single-Photon	1	2016	1143	0.090	Why?
Epilepsies, Partial	1	1995	431	0.090	Why?
Hand Injuries	1	1994	239	0.090	Why?
Carotid Artery, Internal	1	1993	440	0.090	Why?
Facial Injuries	1	2012	190	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2013	696	0.090	Why?
Physostigmine	5	1978	51	0.080	Why?
Aged, 80 and over	13	2016	59496	0.080	Why?
Receptors, N-Methyl-D-Aspartate	2	2009	896	0.080	Why?
Time Factors	10	2013	40097	0.080	Why?
Mobility Limitation	1	2013	409	0.080	Why?
Drug Evaluation	3	2008	642	0.080	Why?
Capsaicin	1	1990	226	0.080	Why?
Diagnosis, Differential	6	2016	12973	0.080	Why?
Somatoform Disorders	1	2012	425	0.080	Why?
Patient Selection	2	2004	4248	0.080	Why?
Reserpine	5	1975	63	0.080	Why?
Status Epilepticus	1	1995	459	0.080	Why?
Aortic Valve Insufficiency	1	1993	575	0.080	Why?
Task Performance and Analysis	1	2013	770	0.080	Why?
Acceleration	1	2010	189	0.080	Why?
Computer Communication Networks	1	2010	292	0.080	Why?
Amino Acid Substitution	5	2010	1740	0.080	Why?
Exercise Test	1	2016	2185	0.080	Why?
Behavior, Animal	6	1977	1866	0.080	Why?
Telemetry	1	2010	201	0.080	Why?
Aphasia	1	2010	192	0.080	Why?
Brain Abscess	1	2009	122	0.080	Why?
Substantia Nigra	5	1978	346	0.070	Why?
Microelectrodes	2	2014	305	0.070	Why?
Face	2	2012	1029	0.070	Why?
Sodium-Potassium-Exchanging ATPase	1	2010	479	0.070	Why?
Picrotoxin	3	1978	61	0.070	Why?
Cyclophosphamide	1	2013	2232	0.070	Why?
Apomorphine	6	1978	148	0.070	Why?
Dihydroxyphenylalanine	4	1977	74	0.070	Why?
Deanol	2	1977	2	0.070	Why?
Nitriles	1	2012	981	0.070	Why?
Cross-Over Studies	2	2016	2108	0.070	Why?
Neck Muscles	2	1997	100	0.070	Why?
Diabetic Neuropathies	1	1990	407	0.070	Why?
Radiopharmaceuticals	1	2016	2701	0.070	Why?
Muscle Rigidity	2	2006	41	0.070	Why?
Hypokinesia	1	2006	23	0.070	Why?
Multicenter Studies as Topic	3	2007	1729	0.070	Why?
Electrodes, Implanted	3	2014	834	0.070	Why?
Movement	1	2013	1460	0.060	Why?
Lasers	1	2010	951	0.060	Why?
Myoclonus	2	1978	107	0.060	Why?
Ethanolamines	2	1977	152	0.060	Why?
Molecular Structure	1	2010	1880	0.060	Why?
Cerebellum	1	2013	1519	0.060	Why?
Affect	1	2013	1494	0.060	Why?
Huntington Disease	4	2000	1147	0.060	Why?
Cholinergic Antagonists	1	2006	165	0.060	Why?
Cues	1	2010	876	0.060	Why?
Caudate Nucleus	2	1978	388	0.060	Why?
Base Sequence	6	2011	12405	0.060	Why?
Calcinosis	1	1993	1475	0.060	Why?
Tranquilizing Agents	5	1977	59	0.060	Why?
Combined Modality Therapy	2	2009	8522	0.060	Why?
Epilepsy	1	2000	3317	0.060	Why?
Disease Progression	3	2012	13614	0.060	Why?
Motor Skills	2	2006	517	0.060	Why?
Molecular Chaperones	1	2009	760	0.060	Why?
Double-Blind Method	7	2016	12417	0.060	Why?
Monoamine Oxidase Inhibitors	1	2004	152	0.060	Why?
Corpus Striatum	8	1978	1218	0.060	Why?
Immunologic Factors	1	2013	1590	0.060	Why?
Indans	1	2004	92	0.060	Why?
Photic Stimulation	1	2010	1992	0.060	Why?
Aortic Valve	1	1993	1964	0.050	Why?
NADH Dehydrogenase	1	2003	45	0.050	Why?
Parkinson Disease, Secondary	5	1984	120	0.050	Why?
Putamen	1	2003	288	0.050	Why?
Pons	1	2003	239	0.050	Why?
Pimozide	4	1975	21	0.050	Why?
Data Collection	1	2011	3318	0.050	Why?
Internet	2	2010	3106	0.050	Why?
Accidental Falls	1	2009	1079	0.050	Why?
Retrospective Studies	7	2014	81537	0.050	Why?
Chlorpromazine	4	1975	111	0.050	Why?
Electromyography	1	2006	1398	0.040	Why?
Piperidines	1	2009	1664	0.040	Why?
Pilot Projects	2	2012	8724	0.040	Why?
Follow-Up Studies	7	2012	39228	0.040	Why?
Survival Analysis	1	2013	10086	0.040	Why?
Muscle Tonus	2	1997	82	0.040	Why?
Time Perception	1	2001	87	0.040	Why?
Phenethylamines	1	2000	95	0.040	Why?
Dose-Response Relationship, Drug	10	2004	10727	0.040	Why?
Clothing	2	2010	95	0.040	Why?
Muscle, Skeletal	2	2010	4959	0.040	Why?
Pain Measurement	3	1999	3558	0.040	Why?
Parasympatholytics	2	1984	89	0.040	Why?
Rotation	3	1975	513	0.040	Why?
Stereotyped Behavior	5	1978	133	0.040	Why?
Long-Term Care	2	2000	630	0.040	Why?
Hand	1	2004	908	0.040	Why?
Decision Making	1	2012	3955	0.040	Why?
Atrophy	1	2003	1629	0.040	Why?
Receptors, Drug	2	1975	156	0.040	Why?
Trifluoperazine	1	1977	40	0.040	Why?
Substance Withdrawal Syndrome	2	1983	627	0.040	Why?
Hepatolenticular Degeneration	1	1978	73	0.040	Why?
Somatosensory Cortex	1	2002	510	0.040	Why?
DNA, Mitochondrial	1	2003	869	0.040	Why?
Excitatory Amino Acid Antagonists	1	2000	451	0.040	Why?
Space Perception	1	2001	469	0.040	Why?
Mutation	3	2011	30192	0.040	Why?
Injections	2	1997	839	0.030	Why?
Catecholamines	2	1976	385	0.030	Why?
Clinical Trials as Topic	6	2007	8037	0.030	Why?
Pyrimidines	1	2009	3049	0.030	Why?
Brain	8	2016	27179	0.030	Why?
Analysis of Variance	2	2016	6202	0.030	Why?
Basal Ganglia	4	1980	549	0.030	Why?
Software	1	2010	4462	0.030	Why?
Parotid Gland	1	2016	177	0.030	Why?
Palliative Care	1	1990	3640	0.030	Why?
Mesencephalon	1	1977	338	0.030	Why?
Norepinephrine	2	1975	898	0.030	Why?
Acute Disease	3	1998	7236	0.030	Why?
Adolescent	8	2011	88811	0.030	Why?
Genetic Variation	1	2010	6612	0.030	Why?
Mental Disorders	2	2011	6870	0.030	Why?
gamma-Aminobutyric Acid	2	1978	1139	0.030	Why?
Clonidine	1	1975	164	0.030	Why?
Reflex Sympathetic Dystrophy	1	1994	60	0.030	Why?
User-Computer Interface	2	2010	1404	0.030	Why?
Chorea	1	1974	80	0.030	Why?
Parasympathomimetics	1	1972	28	0.030	Why?
Intraoperative Complications	1	2000	1169	0.030	Why?
Sympatholytics	1	1972	81	0.030	Why?
Idoxuridine	1	1973	111	0.030	Why?
Sympathomimetics	1	1972	56	0.030	Why?
Activities of Daily Living	2	2006	2414	0.030	Why?
Schizophrenia	4	2006	6971	0.030	Why?
Promethazine	4	1975	29	0.030	Why?
Telemedicine	1	2010	3108	0.020	Why?
Hyperthyroidism	1	1994	292	0.020	Why?
Phenobarbital	3	1981	192	0.020	Why?
Leukoencephalopathy, Progressive Multifocal	1	1973	132	0.020	Why?
Peripheral Nervous System Diseases	1	1997	710	0.020	Why?
Risk Assessment	1	2013	24275	0.020	Why?
Risk Factors	2	2011	74850	0.020	Why?
Untranslated Regions	1	2011	30	0.020	Why?
Meta-Analysis as Topic	1	2016	1366	0.020	Why?
Neurotransmitter Agents	3	1980	663	0.020	Why?
Child	7	2011	80568	0.020	Why?
Age Factors	2	2006	18382	0.020	Why?
Research Design	1	2007	6204	0.020	Why?
Drug Administration Schedule	2	1997	4851	0.020	Why?
Glycerol	1	1971	274	0.020	Why?
Incidence	2	2006	21513	0.020	Why?
Mycetoma	1	1990	18	0.020	Why?
Muscle Contraction	1	1995	1207	0.020	Why?
Peripheral Nerves	1	1994	491	0.020	Why?
Prospective Studies	3	2007	54807	0.020	Why?
Foot	1	1994	575	0.020	Why?
Postoperative Complications	2	2009	15802	0.020	Why?
Myography	1	2010	111	0.020	Why?
Behavior	3	1978	536	0.020	Why?
Range of Motion, Articular	1	1996	1593	0.020	Why?
Age of Onset	2	2009	3343	0.020	Why?
Cognition Disorders	1	2002	3965	0.020	Why?
Transducers	1	2010	238	0.020	Why?
Meningitis	1	1990	218	0.020	Why?
Tomography Scanners, X-Ray Computed	1	2009	170	0.020	Why?
Brain Diseases	1	1977	1552	0.020	Why?
Internationality	1	2013	1007	0.020	Why?
United States	4	2011	72909	0.020	Why?
Animals	19	2003	168735	0.020	Why?
Denervation	2	1980	265	0.020	Why?
Echocardiography, Transesophageal	1	1993	1093	0.020	Why?
Myelitis, Transverse	1	1987	39	0.020	Why?
Video Recording	1	2012	977	0.020	Why?
Nervous System Diseases	1	1978	1657	0.020	Why?
Extremities	1	2012	868	0.020	Why?
Myelitis	1	1987	49	0.020	Why?
Rats	7	1978	23708	0.020	Why?
Cerebral Infarction	1	1971	968	0.020	Why?
Brain Ischemia	1	2000	3000	0.020	Why?
GABA Antagonists	2	1978	120	0.020	Why?
Neuropsychological Tests	2	2014	7116	0.020	Why?
Electric Impedance	1	2010	792	0.020	Why?
Parkinson Disease, Postencephalitic	2	1975	3	0.020	Why?
Autoantibodies	1	1994	2114	0.020	Why?
Specialization	1	1970	779	0.020	Why?
Diazepam	3	1975	215	0.020	Why?
Young Adult	4	2016	59857	0.020	Why?
Dominance, Cerebral	1	2006	616	0.010	Why?
Light	1	2010	1364	0.010	Why?
Acetylcholine	2	1978	628	0.010	Why?
Gene Frequency	1	2011	3623	0.010	Why?
Patient Satisfaction	1	1996	3477	0.010	Why?
Lymph Nodes	1	1995	3447	0.010	Why?
Home Care Services	1	2010	658	0.010	Why?
Chronic Disease	1	1998	9351	0.010	Why?
Exons	1	2009	2393	0.010	Why?
Drug Combinations	1	2009	2075	0.010	Why?
Electroencephalography	2	1995	6274	0.010	Why?
Electron Transport	1	2003	210	0.010	Why?
Neural Inhibition	2	1977	589	0.010	Why?
Nausea	2	1975	678	0.010	Why?
Pedigree	1	2010	4535	0.010	Why?
Psychomotor Performance	2	2002	1882	0.010	Why?
Placebos	2	1997	1659	0.010	Why?
Diabetes Mellitus, Type 1	2	1994	3444	0.010	Why?
Benzodiazepinones	1	1981	50	0.010	Why?
Pain	1	1996	5077	0.010	Why?
Clonazepam	1	1981	135	0.010	Why?
Cytomegalovirus Infections	1	1987	837	0.010	Why?
Single-Blind Method	1	2004	1587	0.010	Why?
DNA Mutational Analysis	1	2009	4111	0.010	Why?
Evoked Potentials, Somatosensory	1	2002	240	0.010	Why?
Receptors, Glutamate	1	2001	228	0.010	Why?
Conserved Sequence	1	2003	1159	0.010	Why?
Cross-Sectional Studies	1	2001	26282	0.010	Why?
Homovanillic Acid	1	1979	73	0.010	Why?
Hydroxyindoleacetic Acid	1	1979	94	0.010	Why?
Synaptic Transmission	2	1977	1178	0.010	Why?
Probenecid	1	1979	72	0.010	Why?
Scopolamine	2	1978	92	0.010	Why?
Perceptual Disorders	1	2001	199	0.010	Why?
Disease Models, Animal	2	1976	18292	0.010	Why?
Magnetic Resonance Imaging	2	2003	36547	0.010	Why?
Phenoxybenzamine	2	1975	53	0.010	Why?
Azores	1	1978	5	0.010	Why?
Benztropine	1	1977	17	0.010	Why?
Stimulation, Chemical	1	1978	303	0.010	Why?
Amino Acid Sequence	1	2010	13398	0.010	Why?
Random Allocation	1	2002	2394	0.010	Why?
Education, Medical	1	1970	1744	0.010	Why?
Magnetoencephalography	1	2002	585	0.010	Why?
Parasympathetic Nervous System	1	1978	144	0.010	Why?
Limbic System	1	1980	418	0.010	Why?
Synapses	2	1979	1758	0.010	Why?
Molecular Sequence Data	1	2010	17596	0.010	Why?
Amphetamine	2	1975	222	0.010	Why?
Carnitine	1	1978	253	0.010	Why?
Paresthesia	1	1997	159	0.010	Why?
Cohort Studies	2	2010	41680	0.010	Why?
Child, Preschool	2	2010	42510	0.010	Why?
Nerve Endings	1	1976	103	0.010	Why?
Genotype	1	2011	13026	0.010	Why?
Sickness Impact Profile	1	1997	297	0.010	Why?
Anti-Bacterial Agents	1	1995	7473	0.010	Why?
Reaction Time	1	2002	2085	0.010	Why?
Mice, Inbred Strains	2	1978	1769	0.010	Why?
Terminology as Topic	1	1983	1536	0.010	Why?
Dibenzazepines	1	1975	26	0.010	Why?
Amphetamines	1	1976	142	0.010	Why?
Methyltyrosines	1	1974	7	0.010	Why?
History, 20th Century	1	1983	2760	0.010	Why?
Haplorhini	1	1976	520	0.010	Why?
Electrophysiology	1	1978	1264	0.010	Why?
Clozapine	2	1975	509	0.010	Why?
Cyclic AMP	1	1979	1466	0.010	Why?
Evolution, Molecular	1	2003	1889	0.010	Why?
Growth Hormone	1	1977	567	0.010	Why?
New England	1	1978	1059	0.010	Why?
Drug Evaluation, Preclinical	1	1980	1331	0.010	Why?
Athetosis	1	1974	15	0.010	Why?
Reproducibility of Results	1	2012	20133	0.010	Why?
Drug Interactions	2	1978	1416	0.010	Why?
Handwriting	1	1974	26	0.010	Why?
Phenothiazines	1	1974	60	0.010	Why?
Hypertension	2	2009	8616	0.010	Why?
Art	1	1974	66	0.010	Why?
gamma-Globulins	1	1973	119	0.010	Why?
Posture	2	1975	955	0.010	Why?
Tomography, X-Ray Computed	2	1993	20690	0.010	Why?
Nerve Degeneration	1	1977	748	0.010	Why?
Electric Stimulation	1	1997	1738	0.010	Why?
Hydroxydopamines	3	1976	59	0.010	Why?
Locomotion	1	1974	384	0.010	Why?
Kidney Transplantation	1	1987	4277	0.010	Why?
Oxidative Stress	1	2003	3140	0.010	Why?
Vomiting	1	1975	646	0.010	Why?
Injections, Intravenous	1	1974	1376	0.010	Why?
Schizophrenic Psychology	1	1978	1645	0.010	Why?
Syndrome	1	1977	3271	0.010	Why?
Skin Tests	1	1973	630	0.010	Why?
Patient Compliance	1	2001	2693	0.010	Why?
Motor Cortex	1	1978	1003	0.010	Why?
Fresh Water	1	1990	82	0.010	Why?
Internship and Residency	1	1970	5945	0.010	Why?
Drug Synergism	1	1973	1751	0.010	Why?
Tyrosine	1	1973	1427	0.010	Why?
Pneumonia, Aspiration	1	1990	145	0.000	Why?
Autopsy	1	1973	1011	0.000	Why?
Mass Screening	1	2004	5449	0.000	Why?
Mice	7	1978	81782	0.000	Why?
Infant	1	2010	36426	0.000	Why?
Cerebral Arteries	1	1990	490	0.000	Why?
Catheterization	1	1973	1426	0.000	Why?
Brain Edema	1	1971	601	0.000	Why?
Sarcoidosis	1	1973	533	0.000	Why?
Genetic Predisposition to Disease	1	2009	18074	0.000	Why?
Dextroamphetamine	2	1978	132	0.000	Why?
Recurrence	1	1978	8492	0.000	Why?
Models, Biological	2	1979	9443	0.000	Why?
Drug Therapy, Combination	1	1975	6306	0.000	Why?
Cerebral Angiography	1	1990	1262	0.000	Why?
Neural Pathways	1	1975	3087	0.000	Why?
Body Weight	1	1974	4627	0.000	Why?
Drug Hypersensitivity	1	1971	903	0.000	Why?
Seizures	1	1975	2997	0.000	Why?
Brain Mapping	1	1975	6598	0.000	Why?
Neurons	1	1979	9527	0.000	Why?
Depression	1	1979	8223	0.000	Why?
Scopolamine Derivatives	1	1978	23	0.000	Why?
Depression, Chemical	1	1976	186	0.000	Why?
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide	1	1975	1	0.000	Why?
Biogenic Amines	1	1975	53	0.000	Why?
Pentobarbital	1	1975	153	0.000	Why?
Isomerism	1	1975	197	0.000	Why?
Antidepressive Agents, Tricyclic	1	1976	427	0.000	Why?
Brain Chemistry	1	1975	952	0.000	Why?
Structure-Activity Relationship	1	1975	3049	0.000	Why?

Tarsy's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (440)

Explore

Co-Authors (28)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors